Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1955 1
1956 1
1959 1
1960 1
1962 3
1963 3
1964 3
1965 1
1966 1
1968 1
1970 1
1971 1
1972 3
1973 1
1974 2
1975 3
1976 4
1977 6
1978 1
1979 5
1980 1
1981 3
1982 4
1983 3
1984 1
1985 5
1986 4
1987 7
1988 9
1989 6
1990 8
1991 3
1992 4
1993 6
1994 3
1995 3
1996 2
1997 7
1998 10
1999 7
2000 19
2001 12
2002 16
2003 18
2004 15
2005 15
2006 12
2007 23
2008 18
2009 19
2010 14
2011 30
2012 24
2013 27
2014 30
2015 39
2016 39
2017 36
2018 33
2019 28
2020 24
2021 25
2022 24
2023 27
2024 27
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

659 results

Results by year

Filters applied: . Clear all
Page 1
Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients.
Dousset L, Chambers DC, Webster A, Isbel N, Campbell S, Duarte C, Collins L, Damian D, Tseng A, Karlsen E, Ilinsky OV, Brown S, Schaider H, Soyer HP, Ospino DA, Hogarth S, Chong AH, Mar V, McKenzie S, Gin D, Fernandez-Penas P, Kern JS, Loewe K, Roy E, Herschtal A, Khosrotehrani K. Dousset L, et al. Among authors: roy e. Trials. 2024 Nov 22;25(1):789. doi: 10.1186/s13063-024-08619-3. Trials. 2024. PMID: 39578921 Free PMC article.
A contest study to reduce attractiveness-based discrimination in social judgment.
Roy E, Jaeger B, Evans AM, Turetsky KM, O'Shea BA, Petersen MB, Singh B, Correll J, Zheng DY, Brown KW, Kirgios EL, Chang LW, Chang EH, Steele JR, Sebastien J, Sedgewick JR, Hackney A, Cook R, Yang X, Korkmaz A, Sim JJ, Khan N, Primbs MA, Bijlstra G, Faure R, Karremans JC, Santos LA, Voelkel JG, Marini M, Chen JM, Brown T, Yoon H, Morewedge CK, Scopelliti I, Hester N, Shen X, Ma M, Medvedev D, Ritchie EG, Lu C, Chang YP, Kumar A, Banerji R, Gretton JD, Schnabel L, Teachman BA, Kristal AS, Chua KW, Freeman JB, Fath S, Grigoryan L, Weißflog MI, Daryani Y, Pourhosein R, Johnson SK, Chan ET, Stevens SM, Anderson S, Beaty RE, Rubichi S, Cocco VM, Vezzali L, Lai CK, Axt JR. Roy E, et al. J Pers Soc Psychol. 2024 Nov 14. doi: 10.1037/pspa0000414. Online ahead of print. J Pers Soc Psychol. 2024. PMID: 39541527 Free article.
Heterojunction semiconductor nanocatalysts as cancer theranostics.
Sabu A, Kandel M, Sarma RR, Ramesan L, Roy E, Sharmila R, Chiu HC. Sabu A, et al. Among authors: roy e. APL Bioeng. 2024 Oct 4;8(4):041502. doi: 10.1063/5.0223718. eCollection 2024 Dec. APL Bioeng. 2024. PMID: 39381587 Free PMC article. Review.
659 results